Format

Send to

Choose Destination
J Cyst Fibros. 2014 Jan;13(1):56-62. doi: 10.1016/j.jcf.2013.07.004. Epub 2013 Aug 8.

Investigating the role of matrix components in protection of Burkholderia cepacia complex biofilms against tobramycin.

Author information

1
Laboratory of Pharmaceutical Microbiology, Ghent University, Harelbekestraat 72, 9000 Ghent, Belgium.
2
Laboratory of Pharmaceutical Microbiology, Ghent University, Harelbekestraat 72, 9000 Ghent, Belgium. Electronic address: Tom.Coenye@Ugent.be.

Abstract

BACKGROUND:

Burkholderia cepacia complex (Bcc) organisms produce a wide variety of potential virulence factors, including exopolysaccharides (EPS), and exhibit intrinsic resistance towards many antibiotics. In the present study we investigated the contribution of Bcc biofilm matrix components, including extracellular DNA, cepacian and poly-β-1,6-N-acetylglucosamine, to tobramycin susceptibility.

METHODS:

The in vitro bactericidal activity of tobramycin in combination with recombinant human DNase (rhDNase), NaClO and dispersin B was tested against Bcc biofilms.

RESULTS:

EPS degradation by NaClO pretreatment and specific PNAG degradation by dispersin B significantly increased the bactericidal effect of tobramycin towards some of the Bcc biofilms tested, including the strains of Burkholderia cenocepacia, B. cepacia and Burkholderia metallica. The presence of rhDNase during biofilm treatment and/or development had no influence on tobramycin activity.

CONCLUSION:

These results suggest that EPS play a role in tobramycin susceptibility of Bcc biofilms and that matrix degrading combination therapy could improve treatment of Bcc biofilm infections.

KEYWORDS:

Biofilm; Burkholderia cepacia complex; Cepacian; Matrix; PNAG; Tobramycin

PMID:
23932109
DOI:
10.1016/j.jcf.2013.07.004
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center